About CORD:USE Cord Blood
CORD:USE Cord Blood is a company based in Orlando (United States) founded in 2004 was acquired by Cryo-Cell in June 2018.. CORD:USE Cord Blood has raised $27.03 million across 5 funding rounds from investors including Cryo-Cell. CORD:USE Cord Blood operates in a competitive market with competitors including Cordlife, LifeCell, ViaCord, Esperite and Cordlife India, among others.
- Headquarter Orlando, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CORD:USE Cord Blood
CORD:USE Cord Blood has successfully raised a total of $27.03M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $250 thousand completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $250,000
-
First Round
First Round
(21 Apr 2011)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2017 | Amount | Series A - CORD:USE Cord Blood | Valuation |
investors |
|
| Mar, 2016 | Amount | Series A - CORD:USE Cord Blood | Valuation |
investors |
|
| Jul, 2015 | Amount | Series A - CORD:USE Cord Blood | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CORD:USE Cord Blood
CORD:USE Cord Blood has secured backing from 1 investor. Prominent investors backing the company include Cryo-Cell. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cord blood and tissue stem cells are stored for preservation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CORD:USE Cord Blood
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CORD:USE Cord Blood
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cord:Use Cord Blood Comparisons
Competitors of CORD:USE Cord Blood
CORD:USE Cord Blood operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cordlife, LifeCell, ViaCord, Esperite and Cordlife India, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cordlife is engaged in cord blood banking and diagnostics.
|
|
| domain | founded_year | HQ Location |
LifeCell is engaged in cord blood banking services.
|
|
| domain | founded_year | HQ Location |
Provider of services for cord blood and stem cell banking
|
|
| domain | founded_year | HQ Location |
Umbilical cord blood stem cells are collected, processed, and stored.
|
|
| domain | founded_year | HQ Location |
Offers stem cell banking services for cord blood and cord lining storage globally.
|
|
| domain | founded_year | HQ Location |
Developer of T-cell therapeutics to treat autoimmune diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CORD:USE Cord Blood
When was CORD:USE Cord Blood founded?
CORD:USE Cord Blood was founded in 2004 and raised its 1st funding round 7 years after it was founded.
Where is CORD:USE Cord Blood located?
CORD:USE Cord Blood is headquartered in Orlando, United States. It is registered at Orlando, Florida, United States.
Is CORD:USE Cord Blood a funded company?
CORD:USE Cord Blood is a funded company, having raised a total of $27.03M across 5 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Apr 21, 2011.
What does CORD:USE Cord Blood do?
CORD:USE Cord Blood was established in 2004 in Orlando, United States, within the biotechnology sector focused on stem cell preservation. Umbilical cord blood from newborns is processed and stored by the company for potential future use by the individual or family members. A public cord blood bank is maintained, where donations are collected, processed, and made available for transplant patients in need.
Who are the top competitors of CORD:USE Cord Blood?
Who are CORD:USE Cord Blood's investors?
CORD:USE Cord Blood has 1 investor. Key investors include Cryo-Cell.